Strategic Research and Innovation Agenda on Antimicrobial Resistance
The Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) 1 is an international collaborative platform coordinating and funding research on antimicrobial resistance (AMR). JPIAMR facilitates alignment of research programmes between member countries, as well as initiating and coordinating international funding initiatives on AMR through its Strategic Research and Innovation Agenda (SRIA). Through implementation of the SRIA, the JPIAMR supports research on the development of new therapies, stewardship of new and existing antibiotics, and strategies to monitor and prevent the spread of AMR between humans, animals, and the environment in a One Health2 perspective, with the overall goal to decrease the burden of AMR. The SRIA defines six priority topics through which coordinated research activities are translated into new and/or improved strategies to address AMR.
The JPIAMR goals are:
• To align national and international research programmes.
• To support and coordinate transformative research.
• To develop the JPIAMR-Virtual Research Institute.
• To promote innovation and translation of research results.
• To bridge the gap between research and policy.
Advancing data technologies to corner AMR 2019
International Matchmaking Symposium on 5 June, 2019 in Amsterdam, The Netherlands.
Artificial Intelligence, Internet-of-Things and Blockchain to stop ever-escalating Antimicrobial resistance.